What are the limitations and challenges of PD-1 inhibitors?
While PD-1 inhibitors have been revolutionary, they are not without limitations. A significant challenge is that not all patients respond to these treatments. Researchers are actively studying biomarkers to predict which patients will benefit from PD-1 inhibitors. Additionally, these therapies can cause immune-related adverse events (irAEs), which require careful management and can sometimes be severe.
